Tag: Millions

Categories
Politics

Pfizer Reaps Lots of of Hundreds of thousands in Income From Covid Vaccine

Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine

Several factors explain the inequality in Pfizer’s vaccine distribution.

The shot, which must be stored and transported at very low temperatures, is less practical for hard-to-reach parts of the world than other shots such as those from AstraZeneca and Johnson & Johnson that can simply be refrigerated. Some poor countries were not hit badly by the virus initially, so their governments had less urgency to place orders for the Pfizer vaccine as far as they could afford to pay for the shots.

“Not everyone was interested in the vaccine or willing to take steps. As a result, talks will continue, including working with Covax beyond the original 40 million cans, ”said Ms. Castillo, Pfizer spokeswoman.

In India, where the virus is spiraling out of control, the Pfizer vaccine is not used. The company applied for an emergency permit there, but withdrew the application in February because the Indian Medicines Agency was unwilling to waive the requirement to conduct a local clinical trial. At the time, India’s coronavirus case numbers were manageable and vaccines made locally were considered sufficient.

Pfizer and the Government of India have since resumed talks. On Monday, Mr Bourla said the company would donate more than $ 70 million worth of drugs to India and is trying to expedite vaccine approval.

Pfizer has made public promises to run its business not only for the enrichment of shareholders but also for the betterment of society.

Mr. Bourla, who earned $ 21 million last year, was among the 181 leaders of large companies who signed a 2019 Business Roundtable pledge to focus on a range of “stakeholders” including workers, suppliers and local communities – not just investors.

The financial numbers Pfizer reported Tuesday underestimate how much money the vaccine will generate. Pfizer is splitting its vaccine sales with BioNTech, which will publish its own first quarter results next week. BioNTech announced in March that it had achieved sales of nearly 10 billion euros, or around 11.8 billion US dollars, based on the vaccine orders it had ordered at the time.

Categories
Health

Shake-Up at Covid Vaccine Producer That Tossed Hundreds of thousands of Doses

Shake-Up at Covid Vaccine Manufacturer That Tossed Millions of Doses

The Baltimore facility is one of two federally designated locations to manufacture vaccines or therapeutics for public health emergencies. In June 2020, the Trump administration placed a $ 628 million contract with Emergent, primarily to reserve space in Baltimore for the manufacture of coronavirus vaccines.

In Washington, Emergent is known for aggressive lobbying and government relations that include both Democratic and Republican governments. The company’s board of directors is made up of former federal officials, and lobbyists include former members of Congress.

“We’ve been around as a company for 22 years,” Kramer said Thursday, adding that the company’s relationships with government agencies, including the biomedical advanced research and development agency known as BARDA, which has spent $ 628 million on the contract , “stay intact and strong.”

In June 2020, shortly after the Trump administration awarded the contract to Emergent, a top official with Operation Warp Speed, the government’s rapid vaccine initiative, warned that the company had insufficiently trained staff and was experiencing quality control issues.

A copy of the official’s assessment received from The Times named “major risks” of relying on Emergent to manufacture vaccines developed by both Johnson & Johnson and AstraZeneca at the same Baltimore facility.

Cross-contamination is a “known risk” in manufacturing two live virus vaccines, Kramer said Thursday, but the decision to manufacture both in Baltimore was with the government. There are several safeguards in place, Emergent said, although Emergent believes they “weren’t working as expected” and that the AstraZeneca virus likely contaminated the Johnson & Johnson batch.

“It’s easy to go back and rethink these decisions that were made in the early stages of the pandemic,” he said. “At the time, nobody knew how quickly we could get into a clinically viable vaccine and which candidates would be most successful.”

Categories
Health

Tens of millions Are Skipping Their Second Doses of Covid Vaccines

Millions Are Skipping Their Second Doses of Covid Vaccines

Millionen Amerikaner erhalten nicht die zweite Dosis ihrer Covid-19-Impfstoffe, und ihre Reihen wachsen.

Mehr als fünf Millionen Menschen oder fast 8 Prozent derjenigen, die zum ersten Mal die Pfizer- oder Moderna-Impfstoffe erhalten haben, haben nach den neuesten Daten der Zentren für die Kontrolle und Prävention von Krankheiten ihre zweite Dosis verpasst. Das ist mehr als das Doppelte der Rate unter Menschen, die in den ersten Wochen der landesweiten Impfkampagne geimpft wurden.

Selbst wenn das Land mit dem Problem von Millionen von Menschen zu kämpfen hat, die sich vor einer Impfung fürchten, stehen die örtlichen Gesundheitsbehörden vor der aufkommenden Herausforderung, sicherzustellen, dass diejenigen, die geimpft werden, dies vollständig tun.

Die Gründe variieren, warum Menschen ihre zweiten Schüsse verpassen. In Interviews sagten einige, sie befürchteten die Nebenwirkungen, zu denen auch flulike Symptome gehören können. Andere sagten, sie fühlten sich mit einem einzigen Schuss ausreichend geschützt.

Diese Einstellungen wurden erwartet, aber eine weitere Hürde war überraschend weit verbreitet. Eine Reihe von Impfstoffanbietern hat Termine für die zweite Dosis abgesagt, weil ihnen das Angebot ausgegangen ist oder sie nicht die richtige Marke auf Lager hatten.

Walgreens, einer der größten Impfstoffanbieter, schickte einige Leute, die einen ersten Schuss des Pfizer- oder Moderna-Impfstoffs erhielten, zu ihren zweiten Dosen in Apotheken, in denen nur der andere Impfstoff zur Verfügung stand.

Mehrere Walgreens-Kunden sagten in Interviews, dass sie, in einigen Fällen mit Hilfe von Apothekenmitarbeitern, nach einem Ort gesucht hätten, an dem sie die richtige zweite Dosis erhalten könnten. Andere gaben vermutlich einfach auf.

Von Anfang an befürchteten Experten des öffentlichen Gesundheitswesens, dass es schwierig sein würde, alle drei oder vier Wochen nach der ersten Dosis zu einem zweiten Schuss zurückzukehren. Es ist keine Überraschung, dass mit der breiteren Einführung von Impfstoffen die Zahl derjenigen, die ihre zweite Dosis auslassen, gestiegen ist.

Trotzdem beunruhigt der Trend einige Staatsbeamte, die sich beeilen, die Zahl der nur teilweise geimpften Menschen vor Schwellungen zu bewahren.

In Arkansas und Illinois haben Gesundheitsbeamte Teams angewiesen, anzurufen, SMS zu schreiben oder Briefe an Personen zu senden, um sie daran zu erinnern, ihre zweiten Schüsse zu bekommen. In Pennsylvania versuchen Beamte sicherzustellen, dass College-Studenten ihre zweiten Aufnahmen machen können, nachdem sie den Campus für den Sommer verlassen haben. South Carolina hat mehrere tausend Dosen speziell für Menschen bereitgestellt, die für ihren zweiten Schuss überfällig sind.

Zunehmende Beweise, die in Studien und aus realen Impfkampagnen gesammelt wurden, deuten auf die Gefahr hin, dass Menschen ihre zweite Dosis auslassen. Im Vergleich zum Zwei-Dosis-Regime löst ein einziger Schuss eine schwächere Immunantwort aus und kann die Empfänger anfälliger für gefährliche Virusvarianten machen. Und obwohl eine Einzeldosis einen teilweisen Schutz gegen Covid bietet, ist nicht klar, wie lange dieser Schutz anhält.

“Ich bin sehr besorgt, weil Sie diese zweite Dosis benötigen”, sagte Dr. Paul Offit, Professor an der University of Pennsylvania und Mitglied des Impfstoffbeirats der Food and Drug Administration.

Was Sie über die Johnson & Johnson Vaccine Pause in den USA wissen müssen

    • Am 23. April stimmte ein Beratergremium der Zentren für die Kontrolle und Prävention von Krankheiten dafür, eine Pause für den Impfstoff von Johnson & Johnson Covid aufzuheben und ein Etikett über eine äußerst seltene, aber möglicherweise gefährliche Blutgerinnungsstörung anzubringen.
    • Von den Gesundheitsbehörden des Bundes wird erwartet, dass sie den Staaten offiziell empfehlen, die Pause aufzuheben.
    • Die Verabreichung des Impfstoffs wurde kürzlich eingestellt, nachdem Berichte über eine seltene Blutgerinnungsstörung bei sechs Frauen aufgetaucht waren, die den Impfstoff erhalten hatten.
    • Das Gesamtrisiko für die Entwicklung der Störung ist äußerst gering. Frauen zwischen 30 und 39 Jahren scheinen mit 11,8 Fällen pro Million Dosen am stärksten gefährdet zu sein. Es gab sieben Fälle pro Million Dosen bei Frauen zwischen 18 und 49 Jahren.
    • Mittlerweile wurden fast acht Millionen Dosen des Impfstoffs verabreicht. Bei Männern und Frauen ab 50 Jahren gab es weniger als einen Fall pro Million Dosen.
    • Johnson & Johnson hatte auch beschlossen, die Einführung seines Impfstoffs in Europa aus ähnlichen Gründen zu verschieben, entschied sich jedoch später, seine Kampagne fortzusetzen, nachdem die Arzneimittelbehörde der Europäischen Union die Hinzufügung eines Warnhinweises angekündigt hatte. Südafrika, das von einer ansteckenden Virusvariante am Boden zerstört wurde, stellte die Verwendung des Impfstoffs ebenfalls ein, setzte ihn jedoch später fort.

Es steht viel auf dem Spiel, da in den USA nur ein Impfstoff zugelassen ist, der als Einzelschuss verabreicht wird. Die Verwendung dieses Impfstoffs von Johnson & Johnson wurde diesen Monat unterbrochen, nachdem er mit einer sehr seltenen, aber schwerwiegenden Nebenwirkung der Blutgerinnung in Verbindung gebracht worden war. Die Gesundheitsbehörden des Bundes haben am Freitag empfohlen, die Verwendung des Impfstoffs wieder aufzunehmen, aber die Kombination aus Sicherheitsbedenken und anhaltenden Produktionsproblemen dürfte diesen Impfstoff zu einer praktikablen Option für weniger Menschen machen.

Die Anzahl der versäumten zweiten Dosen der CDC reicht bis zum 9. April. Sie gilt nur für Personen, die bis zum 7. März eine erste Moderna-Dosis oder bis zum 14. März eine erste Pfizer-Dosis erhalten haben.

Während Millionen von Menschen ihre zweiten Schüsse verpasst haben, sind die Gesamtquoten der Nachsorge, bei denen rund 92 Prozent vollständig geimpft sind, im historischen Vergleich hoch. Ungefähr drei Viertel der Erwachsenen kommen zurück, um ihre zweite Dosis des Impfstoffs zu erhalten, der vor Gürtelrose schützt.

In einigen Fällen können Probleme mit Sendungen oder der Planung eine Rolle spielen, wenn Personen ihre zweite Dosis verpassen. Einige Impfstoffanbieter mussten Termine absagen, weil sie keine erwarteten Impfstofflieferungen erhalten hatten. Die Leute haben auch berichtet, dass ihre Termine für die zweite Dosis abgesagt wurden oder nur aufgetaucht sind, um herauszufinden, dass keine Dosen der Marke verfügbar waren, die sie brauchten.

Einige Leute können flexibel sein, wenn sie umgebucht werden. Dies ist jedoch schwieriger für Menschen, die keinen Zugang zu zuverlässigen Transportmitteln haben oder Jobs mit genau festgelegten Arbeitszeiten haben, sagte Elena Cyrus, Epidemiologin für Infektionskrankheiten an der Universität von Zentralflorida.

Aktualisiert

24. April 2021, 22.42 Uhr ET

Walgreens buchte einige Kunden für ihre zweiten Termine an Orten, an denen nicht der gleiche Impfstoff vorhanden war, den sie für ihre Anfangsdosen erhalten hatten. Das Unternehmen sagte, es habe das Problem Ende März behoben.

Susan Ruel, 67, sollte ihre beiden Impfstoffdosen in verschiedenen Walgreens-Läden in Manhattan erhalten. Sie sagte, sie habe ihre erste Pfizer-Dosis ohne Zwischenfälle im Februar erhalten, aber als sie zu ihrem zweiten Termin ankam, wurde ihr gesagt, dass der Laden nur Moderna-Dosen auf Lager habe.

Ein Walgreens-Apotheker sagte Frau Ruel, dass es eine andere Walgreens-Apotheke in weniger als drei Kilometern Entfernung gibt, in der Pfizer-Dosen auf Lager sind. Während Frau Ruel darauf wartete, dass die U-Bahn sie dorthin brachte, bekam sie einen Anruf: In diesem Walgreens-Laden waren auch die Pfizer-Dosen ausgegangen.

Frau Ruel schaffte es am nächsten Tag, die Pfizer-Dosis bei einem weiteren Walgreen zu bekommen. Aber sie sagte, viele Menschen in ihrer Situation hätten sich wahrscheinlich nicht so sehr bemüht. “Alles, was Sie brauchen, ist Ärger wie dieser”, sagte sie.

In der Region Chicago beispielsweise sagten Apotheker an zwei Walgreens-Standorten, das Problem verursache Kopfschmerzen. Sie sagten, dass das Terminsystem von Walgreens jede Apotheke zwischen 10 und 20 Kunden pro Woche schickte, die einen zweiten Pfizer-Schuss benötigen, obwohl beide Apotheken nur den Moderna-Impfstoff auf Lager haben.

Es ist nicht klar, wie weit verbreitet das Problem der Walgreens-Dosisanpassung war oder wie viele Menschen ihre zweite Dosis aufgrund dessen verpasst haben.

Jim Cohn, ein Sprecher von Walgreens, sagte, dass das Problem “einen kleinen Prozentsatz” der Personen betraf, die ihre Termine online gebucht hatten, und dass das Unternehmen sie kontaktierte, um “im Einklang mit unserer Impfstoffverfügbarkeit” einen neuen Termin zu vereinbaren. Er sagte, dass fast 95 Prozent der Menschen, die ihren ersten Schuss bei Walgreens bekommen haben, auch ihren zweiten Schuss von der Firma erhalten haben.

Walgreens ist auch unter Beschuss geraten, weil bis vor kurzem vier Wochen nach dem ersten Schuss eine zweite Dosis des Pfizer-Impfstoffs geplant wurde, anstatt dass die von den CDC-Apothekern empfohlene dreiwöchige Lücke von Kunden belagert wurde, die sich beschwerten, einschließlich ihrer Unfähigkeit zu buchen Impfstoff Termine online.

In anderen Fällen ist der Zugang zu Impfstoffen jedoch nicht die einzige Barriere. Auch die Einstellungen der Menschen tragen dazu bei.

Basith Syed, eine 24-jährige Beraterin in Chicago, schnappte sich Mitte Februar bei einem Walgreens einen übrig gebliebenen Moderna-Impfstoff. Aber als die Zeit für seinen zweiten Schuss kam, war er bei der Arbeit beschäftigt und bereitete sich auf seine Hochzeit vor. Nach dem ersten Schuss hatte er zwei Tage damit verbracht, sich ausgelaugt zu fühlen. Er wollte keine Wiederholung riskieren und war zuversichtlich, dass eine einzige Dosis ihn schützen würde.

“Ich fühlte nicht wirklich die Dringlichkeit, diese zweite Dosis zu bekommen”, sagte Herr Syed.

Anfang April hatte sich sein Zeitplan etwas beruhigt und er suchte nach einem zweiten Moderna-Schuss. Aber bis dahin boten die Walgreens, auf denen er seinen ersten Schuss bekommen hatte, nur Pfizer-Schüsse an. Er konnte keine Slots in anderen Walgreens-Läden finden. Mr. Syed sucht nicht mehr aktiv nach einem zweiten Schuss, obwohl er immer noch hofft, irgendwann einen zu bekommen.

.

Laut CDC gibt es nur begrenzte Daten zur Wirksamkeit des Impfstoffs, wenn die Schüsse mehr als sechs Wochen voneinander entfernt sind, obwohl einige Länder, darunter Großbritannien und Kanada, Schüsse mit einem Abstand von bis zu drei oder vier Monaten abgeben.

Die Erfahrung von Herrn Syed ist Teil einer umfassenderen Verschiebung in Illinois. Als Impfstoffe hauptsächlich an Mitarbeiter des Gesundheitswesens, Bewohner von Langzeitpflegeeinrichtungen und Menschen über 65 verabreicht wurden, bekam fast jeder seinen zweiten Schuss. In den letzten Wochen ist die Zahl jedoch unter 90 Prozent gesunken, obwohl sie sich laut dem Illinois Department of Public Health seitdem leicht erholt hat.

In Arkansas haben ungefähr 84.000 Menschen ihre zweiten Schüsse verpasst, was 11 Prozent derjenigen entspricht, die für diese Schüsse in Frage kommen, sagte Dr. Jennifer Dillaha, die staatliche Epidemiologin. Vor kurzem haben Arbeiter angefangen, Leute anzurufen, die für ihre zweiten Schüsse fällig oder überfällig sind.

College-Studenten stellen eine besondere Herausforderung dar. Viele haben sich kürzlich für eine Impfung qualifiziert und bekommen ihre ersten Schüsse, aber sie werden den Campus verlassen haben, wenn sie für ihre zweite Dosis fällig sind.

In Pennsylvania haben Gesundheitsbeamte Impfstoffanbieter angewiesen, College-Studenten zweite Dosen zu verabreichen, auch wenn sie ihre ersten Dosen nicht von diesem Ort erhalten haben.

Einige Impfstoffanbieter haben spezielle Kliniken für Menschen eingerichtet, die eine zweite Dosis benötigen. In South Carolina startete das Gesundheitssystem Tidelands Health ein Programm speziell für Menschen, die ihre ersten Pfizer-Dosen mehr als 23 Tage zuvor erhalten hatten, aber keinen zweiten Schuss finden konnten. Das staatliche Gesundheitsamt schickte dem Gesundheitssystem 2.340 Dosen für die Bemühungen.

Die Nachfrage war stark und Tidelands hat nur noch wenige hundert Dosen übrig. Die Mehrheit der Abnehmer waren Personen, die “Schwierigkeiten hatten, durch die verschiedenen Planungssysteme und Anbieter zu navigieren”, sagte Gayle Resetar, Chief Operating Officer des Gesundheitssystems.

In vielen Fällen hatten Impfstoffanbieter Termine für die zweite Dosis wegen schlechten Winterwetters abgesagt. “Es war Sache des Einzelnen, sich auf einem Webportal oder einer Webplattform neu zu planen, und das wurde für die Menschen einfach schwierig”, sagte Frau Resetar.

Es gibt seltene Fälle, in denen Menschen auf den zweiten Schuss verzichten sollen, beispielsweise wenn sie nach dem ersten Schuss eine allergische Reaktion hatten.

Zvi Ish-Shalom, ein Professor für Religionswissenschaft aus Boulder, Colorado, hatte geplant, sich vollständig impfen zu lassen. Dann, eine Stunde nach seiner ersten Aufnahme des Moderna-Impfstoffs, bekam er Kopfschmerzen, die erst einen Monat später verschwunden waren.

Es gibt keine Möglichkeit, sicher zu wissen, ob der Impfstoff die Kopfschmerzen ausgelöst hat. Nachdem Dr. Ish-Shalom die Risiken und Vorteile einer zweiten Dosis abgewogen hatte, traf er eine Entscheidung über das weitere Vorgehen.

“Zu diesem Zeitpunkt fühle ich mich angesichts all der verschiedenen Elemente dieser Gleichung sehr klar und sehr wohl, auf den zweiten Schuss zu verzichten”, sagte er.

Categories
Health

Vaccines Received’t Defend Thousands and thousands of Sufferers With Weakened Immune Programs

Vaccines Won’t Protect Millions of Patients With Crippled Immune Systems

Dr. Andrew Wollowitz has been at the monastery for the most part at his Mamaroneck, NY home for more than a year

As medical director for emergency medicine at Montefiore Medical Center in the Bronx, 63-year-old Dr. Wollowitz eager to treat patients when the coronavirus raged in town last spring. However, cancer treatment in 2019 had wiped out his immune cells, leaving him defenseless against the virus. Instead, he arranged for his employees to be managed through Zoom.

A year later, people return to Dr. Wollowitz’s life returned to a semblance of normalcy. His wife, dancer and choreographer, is preparing to work for the Austrian National Ballet Company. His vaccinated friends meet, but he only sees them when the weather is nice enough to sit in his back yard. “I spend very little time in public areas,” he said.

Like his friends, Dr. Wollowitz vaccinated in January. But he wasn’t producing antibodies in response – and he hadn’t expected it either. He is one of millions of Americans with weakened immune systems whose bodies cannot learn to use immune fighters against the virus.

Some immunocompromised people were born with missing or faulty immune systems, while others, like Dr. Wollowitz, have illnesses or have received therapies that wipe out their immune defenses. Many of them make little to no antibodies in response to a vaccine or infection, which makes them susceptible to the virus. If infected, they can suffer from prolonged illness, with a death rate of up to 55 percent.

Most people who have lived with immunodeficiency for a long time are probably aware of their vulnerability. However, others have no idea that drugs could put them at risk.

“They’ll be walking around outside thinking they’re protected – but maybe not,” said Dr. Lee Greenberger, scientific director of the Leukemia Lymphoma Society, which funds research into blood cancer.

The only recourse for these patients – other than housing until the virus is withdrawn – may be to regularly infuse monoclonal antibodies, which are mass-produced copies of antibodies obtained from people who have contracted Covid-19 have recovered. The Food and Drug Administration has approved several monoclonal antibody treatments for Covid-19, but some are now also being tested to prevent infection.

Convalescent plasma or gamma globulin – antibodies distilled from the blood of healthy donors – can also help immunocompromised people, although a version of the latter that contains antibodies to the coronavirus is still months away from being available.

“It is a clear area where the need cannot be met,” said Hala Mirza, a spokeswoman for Regeneron, who made their monoclonal antibody cocktail available to a handful of immunocompromised patients through a compassionate application program. (Regeneron released experimental results this week showing the cocktail reduced symptomatic infections by 81 percent in people with normal immune systems.)

It is unclear how many immunocompromised people do not respond to coronavirus vaccines. But the list seems to include at least blood cancer survivors, organ transplant recipients, and anyone taking the widely available drug Rituxan or the cancer drugs Gazyva or Imbruvica – all of which kill or block B cells, the immune cells that develop antibodies – or Remicade, a popular one Drug used to treat inflammatory bowel disease. It can also include some people over the age of 80 whose immune responses have stalled with age.

“We are extremely concerned and interested in finding out how we can help these particular patients,” said Dr. Elad Sharon, an immunotherapy expert at the National Cancer Institute.

As the pandemic spread, doctors who specialized in treating blood cancer or caring for immunocompromised people expected at least some of their patients to encounter difficulties. Dr. Charlotte Cunningham-Rundles, an immunologist at the Icahn School of Medicine on Mount Sinai in New York, has about 600 patients who rely almost exclusively on regular doses of gamma globulin to protect against pathogens.

Nevertheless, 44 of their patients became infected with the coronavirus; four died and another four or five had long-term illnesses. (Chronic infections can give the virus the opportunity to develop into dangerous variants.)

Steven Lotito, 56, one of Dr. Cunningham-Rundles, was diagnosed with a condition known as common variable immunodeficiency when he was 13 years old. Before the pandemic, he had an active lifestyle, exercised, and ate well. “I’ve always known that I take special care of my body,” he said. This included infusions of gamma globulin every three weeks.

Despite careful precautionary measures, Mr Lotito caught the virus from his daughter in mid-October. He had a fever for almost a month and spent a week in the hospital. Convalescent plasma and remdesivir, an antiviral drug, provided relief for a few weeks, but his fever returned. After another infusion of gamma globulin that sweated through four shirts, he finally felt better.

Updated

April 18, 2021, 11:00 p.m. ET

Nevertheless, after almost seven weeks of illness, Mr. Lotito no longer had any antibodies to show. “I still have to take the same precautions that I took a year ago,” he said. “It’s a little daunting.”

People like Lotito-san rely on those around them to get vaccinated to keep the virus at bay, said Dr. Cunningham-Rundles.

“They hope that all of your family members and all of your close co-workers will go out and get a shot, and they will protect you with herd immunity,” she said. “You have to start with that.”

Dr. Cunningham-Rundles has tested their patients for antibodies and has registered some for Regeneron’s monoclonal antibody cocktail. However, many other people with these conditions are unaware of their risks or treatment options.

The Leukemia Lymphoma Society has set up a registry to provide information and antibody tests to people with blood cancer. Several studies are looking at the response to coronavirus vaccines in people with cancer, autoimmune diseases like lupus or rheumatoid arthritis, or in patients taking drugs that suppress the immune response.

What You Need To Know About The Johnson & Johnson Vaccine Break In The United States

    • On April 13, 2021, U.S. health officials called for an immediate halt to use of Johnson & Johnson’s single-dose Covid-19 vaccine after six recipients in the U.S. developed a rare blood clot disorder within one to three weeks of being vaccinated.
    • All 50 states, Washington, DC, and Puerto Rico have temporarily stopped using the vaccine or recommended providers are suspending use of the vaccine. The U.S. military, government-run vaccination centers, and a variety of private companies, including CVS, Walgreens, Rite Aid, Walmart, and Publix, also paused the injections.
    • Fewer than one in a million Johnson & Johnson vaccinations are currently being studied. If there is indeed a risk of blood clots from the vaccine – which has yet to be determined – the risk is extremely small. The risk of contracting Covid-19 in the United States is much higher.
    • The hiatus could complicate the country’s vaccination efforts at a time when many states are facing spikes in new cases and are trying to address vaccine hesitation.
    • Johnson & Johnson has also decided to delay the launch of its vaccine in Europe amid concerns about rare blood clots, which is taking another blow to the vaccine surge in Europe. South Africa, devastated by a contagious variant of the virus found there, also stopped using the vaccine. Australia announced that it would not buy cans.

In one such study, British researchers tracked nearly 7,000 people with Crohn’s disease or ulcerative colitis from 90 hospitals across the country. They found that less than half of the patients who took Remicade had an immune response after contracting coronavirus infection.

In a follow-up, the scientists found that 34 percent of people who took the drug were protected after a single dose of the Pfizer vaccine and only 27 percent after a single dose of the AstraZeneca vaccine. (In the UK, the current practice is to delay second doses to increase vaccine availability.)

Likewise, another study published last month showed that fewer than 15 percent of patients with blood or immune cancer and fewer than 40 percent of patients with solid tumors produced antibodies after receiving a single dose of the Pfizer BioNTech vaccine.

And a study published last month in the journal JAMA reported that only 17 percent of the 436 transplant recipients who received a dose of the Pfizer BioNTech or Moderna vaccine had detectable antibodies three weeks later.

Despite the small likelihood, immunocompromised people should receive the vaccines because they may produce some immune cells that protect, even antibodies in a subset of patients.

“These patients should likely be prioritized for optimally balanced two doses,” said Dr. Tariq Ahmad, gastroenterologist with the Royal Devon and Exeter NHS Foundation Trust who was involved in the infliximab studies.

He suggested that doctors routinely measure antibody responses in immunocompromised people even after two doses of vaccine to identify those who may also need monoclonal antibodies to prevent infection or a third dose of the vaccines.

Wendy Halperin, 54, was diagnosed with a condition known as common variable immunodeficiency when she was 28 years old. She was hospitalized with Covid-19 in January and stayed there for 15 days. However, the coronavirus caused unusual symptoms.

“I had trouble walking,” she recalled. “I just lost control of my limbs like I couldn’t walk down the street.”

Since she was being treated for convalescence plasma for Covid-19, Ms. Halperin had to wait three months for the immunization and has made an appointment for April 26th. However, despite her condition, her body managed to produce some antibodies against the initial infection.

“The takeaway message is that everyone should try to get the vaccine,” said Dr. Amit Verma, oncologist at Montefiore Medical Center.

Gambling has settled in Dr. Wollowitz’s case not paid off. With no antibodies in his system to protect him, he still works from home – a privilege he is grateful for. He was an avid mountain biker and advanced skier both at risk of injury, but he is playing it safe with the coronavirus.

In anticipation of a return to his normal lifestyle, Dr. Wollowitz his bicycles. But he said he had foreseen he would live like this until enough other people are vaccinated and the number of infections in the city drops.

“I’m not exactly sure what that date is,” he said. “I’m really waiting to get out again.”

Categories
World News

‘Roaring Kitty’ forgoes fast GameStop choices payday within the tens of millions, raises stake

'Roaring Kitty' Keith Gill defends GameStop posts, says he is as bullish as ever on the stock

Keith Gill, the favorite of the Reddit trading people and the man who inspired the epic GameStop Short Squeeze, just doubled his bet on the video game dealer and foregoing a quick million dollar win to increase his stake.

The investor, who offers DeepF —— Value on Reddit and Roaring Kitty on YouTube, exercised his 500 GameStop call option contracts as they expired on Friday, giving him 50,000 more shares at an exercise price of only 12 USD. If he had sold the options at Friday’s price, he could have made more than $ 7 million on the bet.

In addition to exercising these options contracts, Gill bought 50,000 more GameStop shares and increased his total investment to 200,000 shares valued at more than $ 30 million.

While he’s been giving up the quick payday on this options trading, his long investment is now even wilder profitable at its average cost of $ 55.17, according to Gill’s latest update on the Reddit r / WallStreetBets forum on Friday. GameStop closed at $ 154.69 on Friday, bringing it to a profit of nearly $ 20 million. (The post hasn’t been independently verified by CNBC so we’ll assume it’s his actual account.)

Gill attracted an army of day traders who piled into the stationary video game and call options, propelling stocks up 400% in a single week in January. GameStop is up 720% over the year.

Shares rose slightly after close of business with some investors, perhaps encouraging Gill to exercise his call options to get even longer.

The investor was a former Massachusetts Mutual Life Insurance marketer. Through YouTube videos and Reddit posts, Gill encouraged a group of retailers to drive out hedge fund short selling on GameStop.

The action got so wild at one point that brokers, including Robinhood, had to restrict trading in stocks as it blew up their clearinghouse margin. The mania also led to a series of Congressional hearings where Gill discussed broker practices and retail gamifying.

Gill owned 10,000 shares of GameStop at the end of 2020 and increased his stake to 50,000 shares in January and 100,000 shares in mid-February. Judging by the updates he posted on Reddit, he has not sold his GameStop stakes in the incredibly short period of time or in the period that followed.

The GameStop story is far from over. In addition to reviewing the retail saga, the company is itself in the midst of a transformation and hopes to capitalize on the massive price rally.

GameStop announced a $ 1 billion stock sale in early April to accelerate the transition to e-commerce led by activist investor and board member Ryan Cohen, co-founder of Chewy. The company also hired former Amazon and Google CEO Jenna Owens as its new chief operating officer.

Did you like this article?
For exclusive stock selection, investment ideas and CNBC Global Livestream
Sign up for CNBC Pro
Start your free trial now

Categories
Politics

Hometown Worldwide, NJ deli proprietor, value hundreds of thousands in inventory

Hometown International, NJ deli owner, worth millions in stock

He’s a legend in New Jersey high school wrestling – and a mystery in the stock market.

Paul Morina, the principal of Paulsboro, New Jersey, High School is listed in the financial records as the president, CEO, CFO, and more of a Nevada-incorporated company whose shares trade at levels that have a valuation of more than 100 million US dollar results.

That’s an oddly high rating given that Hometown International owns one deli – and only one small deli – in Paulsboro, where the Morina-trained high school wrestling team often wins state championships. The company announced that it has shareholders based in China’s Macau Territory.

Your Hometown Deli business had combined sales of only $ 35,000 for the past two years, according to Hometown International’s annual report filed with the Securities and Exchange Commission on March 26th.

Hedge fund manager David Einhorn mentioned Hometown International in a letter to clients Thursday warning of the risks to retail investors.

“The pastrami has to be amazing,” Einhorn told the company, whose shares rose from $ 3.25 per share to over $ 9 per share from late March 2020 to early September, despite the delicatessen business – the only operating business – due to the coronavirus -Pandemic was closed during this time frame.

Hometown International’s annual report shows that Morina, who is also the company’s treasurer and director, owns 1.5 million common shares of the company and guarantees an additional 30 million shares. Morina owns 19% of Hometown’s outstanding 7.79 million common stock.

On Thursday, Hometown’s stock, which is barely traded on the over-the-counter market, closed at $ 13.50 per share.

That alone is Morina’s common stock worth $ 20.5 million – at least on paper.

FactSet data shows that in Hometown, rarely more than a few hundred stocks change hands per day, and often days when no stocks are exchanged.

CNBC has approached Morina for comment, whose biography on SEC files states that as a coach he has won 25 class state championships with more than 550 wins.

This biography does not imply that Morina had any previous experience in the food service industry.

Nonetheless, Hometown International said in its filing: “We believe that Mr. Morina is a valuable member of our Board of Directors because of his extensive knowledge and experience.”

Filing states that Hometown International, which was founded in 2014, has signed a lease agreement with Mantua Creek Group, which Morina is part of, for their retail space.

The hometown vice president and secretary is Christine Lindenmuth – a 46-year-old math teacher at Paulsboro High School.

Lindenmuth, who did not immediately respond to requests for comments, also appears to have no experience in food service.

However, Hometown International believes that her “in-depth knowledge and experience” also makes her a valued business leader.

According to the SEC filing, Lindenmuth does not hold any shares in the company.

The annual report states: “The company currently has no full-time employees other than its officers and directors, Paul F. Morina, President, and Christine T. Lindenmuth.” It adds, “Both are currently working for the company without compensation.”

Hometown’s annual report suggests that the company was founded with the idea of ​​creating a chain of stores with “a new delicatessen concept”.

“Through our wholly-owned subsidiary, Your Hometown Deli Limited Liability Company (‘Your Hometown Deli’), we operate a deli that offers sandwiches and other ‘home-style’ entrees in a casual and friendly atmosphere,” the file says .

“The store is designed to provide a convenient hangout for local customers of all ages. The company’s first unit was built in Paulsboro, New Jersey and is aimed at smaller towns and cities.”

But that location, a low, box-shaped building just across the Delaware River from Philadelphia, is still the only business the company owns after about seven years of operation.

The company’s chairman, according to its annual report, is Peter Coker Jr., who does not own any shares in Hometown International.

According to Coker’s biography in the company’s annual report, the 1990 Lehigh University graduate has been chairman of South Shore Holdings Limited, a Hong Kong-listed company, since 2013.

Coker is also said to have been the managing partner of Pacific Advisers from 2009 to 2013 and a partner in a Shenzhen, China-based private equity firm called TDR Capital Investment Ltd. was.

“From 2006 to 2009, Mr. Coker was Chairman of Global Trading Offshore Pte (Singapore),” the file reads. “From 2002 to 2005, Mr. Coker was Chairman of Wellington Securities, New Zealand. Mr. Coker was an officer of the Bridge Companies prior to joining Wellington Securities, New Zealand in 2002.”

Coker’s father, North Carolina-based Peter Coker Sr., is listed on the SEC as the holder of 63,334 common shares in Hometown International, with warrants for an additional 1.26 million shares.

CNBC has asked both cokers to comment.

Other Hometown stock owners include Blackwell Partners LLC, Series A, with an address in Hong Kong; and two other companies in Hong Kong, Star V Partners LLC and Maso Capital Investments Limited.

Four other companies or organizations listed as shareholders in Hometown International are based in Macau, China.

One of the companies in Macau, VCH Limited, entered into a consultancy agreement with Hometown International in May 2020.

“As part of this agreement, VCH was hired as an advisor to the company, including building and building a presence with wealthy and institutional investors,” Hometown said in its annual report.

“The term of the agreement is one year. Provided that either party has the right to terminate the agreement after 30 days’ prior written notice to the other party,” the report said.

“Under the agreement, VCH will receive $ 25,000 per month for the life of the agreement, in addition to reimbursement of company pre-approved expenses.”

Hometown International posted a loss of $ 624,438 for 2020 and a loss of $ 153,930 for 2019, according to the company’s annual report.

Much of the company’s 2020 cost increases came from $ 320,000 in so-called “consultancy fees.”

The elder Coker has been identified in other SEC filings, as has the founder and CEO of Tryon Capital Ventures, a North Carolina company that has an advisory agreement with Hometown that pays Tryon $ 15,000 per month.

“We are assuming that the term of the consulting contract with Tryon will be extended by another year,” says the annual report.

Categories
Business

Vaccines Gained’t Shield Hundreds of thousands of Sufferers With Crippled Immune Methods

Vaccines Won’t Protect Millions of Patients With Crippled Immune Systems

Dr. Howard Wollowitz has been at the monastery for the most part at his Mamaroneck, NY home for more than a year

As chief of emergency medicine at Montefiore Medical Center in the Bronx, 63-year-old Dr. Wollowitz eager to treat patients when the coronavirus raged in town last spring. However, cancer treatment in 2019 had wiped out his immune cells, leaving him defenseless against the virus. Instead, he arranged for his employees to be managed through Zoom.

A year later, people return to Dr. Wollowitz’s life returned to a semblance of normalcy. His wife, dancer and choreographer, is preparing to work for the Austrian National Ballet Company. His vaccinated friends meet, but he only sees them when the weather is nice enough to sit in his back yard. “I spend very little time in public areas,” he said.

Dr. Wollowitz, like his friends, was vaccinated in January. But he wasn’t producing antibodies in response – and he hadn’t expected it either. He is one of millions of Americans with weakened immune systems whose bodies cannot learn to use immune fighters against the virus.

Some immunocompromised people were born with missing or faulty immune systems, while others, like Dr. Wollowitz, have illnesses or have received therapies that wipe out their immune defenses. Many of them make little to no antibodies in response to a vaccine or infection, which makes them susceptible to the virus. If infected, they can suffer from prolonged illness, with a death rate of up to 55 percent.

Most people who have lived with immunodeficiency for a long time are probably aware of their vulnerability. However, others have no idea that drugs could put them at risk.

“They’ll be walking around outside thinking they’re protected – but maybe not,” said Dr. Lee Greenberger, scientific director of the Leukemia Lymphoma Society, which funds research into blood cancer.

The only recourse for these patients – other than housing until the virus is withdrawn – may be to regularly infuse monoclonal antibodies, which are mass-produced copies of antibodies obtained from people who have contracted Covid-19 have recovered. The Food and Drug Administration has approved several monoclonal antibody treatments for Covid-19, but some are now also being tested to prevent infection.

Convalescent plasma or gamma globulin – antibodies distilled from the blood of healthy donors – can also help immunocompromised people, although a version of the latter that contains antibodies to the coronavirus is still months away from being available.

“It is a clear area where the need cannot be met,” said Hala Mirza, a spokeswoman for Regeneron, who made their monoclonal antibody cocktail available to a handful of immunocompromised patients through a compassionate application program. (Regeneron released experimental results this week showing the cocktail reduced symptomatic infections by 81 percent in people with normal immune systems.)

It is unclear how many immunocompromised people do not respond to coronavirus vaccines. But the list seems to include at least blood cancer survivors, organ transplant recipients, and anyone taking the widely available drug Rituxan or the cancer drugs Gazyva or Imbruvica – all of which kill or block B cells, the immune cells that develop antibodies – or Remicade, a popular one Drug used to treat irritable bowel disease. It can also include some people over the age of 80 whose immune responses have stalled with age.

“We are extremely concerned and interested in finding out how we can help these particular patients,” said Dr. Elad Sharon, an immunotherapy expert at the National Cancer Institute.

As the pandemic spread, doctors who specialized in treating blood cancer or caring for immunocompromised people expected at least some of their patients to encounter difficulties. Dr. Charlotte Cunningham-Rundles, an immunologist at the Icahn School of Medicine on Mount Sinai in New York, has about 600 patients who rely almost exclusively on regular doses of gamma globulin to protect against pathogens.

Nevertheless, 44 of their patients became infected with the coronavirus; four died and another four or five had long-term illnesses. (Chronic infections can give the virus the opportunity to develop into dangerous variants.)

Steven Lotito, 56, one of Dr. Cunningham-Rundles, was diagnosed with a condition known as common variable immunodeficiency when he was 13 years old. Before the pandemic, he had an active lifestyle, exercised, and ate well. “I’ve always known that I take special care of my body,” he said. This included infusions of gamma globulin every three weeks.

Despite careful precautionary measures, Mr Lotito caught the virus from his daughter in mid-October. He had a fever for almost a month and spent a week in the hospital. Convalescent plasma and remdesivir, an antiviral drug, provided relief for a few weeks, but his fever returned. After another infusion of gamma globulin that sweated through four shirts, he finally felt better.

Updated

April 15, 2021, 2:02 p.m. ET

Nevertheless, after almost seven weeks of illness, Mr. Lotito no longer had any antibodies to show. “I still have to take the same precautions that I took a year ago,” he said. “It’s a little daunting.”

People like Lotito-san rely on those around them to get vaccinated to keep the virus at bay, said Dr. Cunningham-Rundles.

“They hope that all of your family members and all of your close co-workers will go out and get a shot, and they will protect you with herd immunity,” she said. “You have to start with that.”

Dr. Cunningham-Rundles has tested their patients for antibodies and has registered some for Regeneron’s monoclonal antibody cocktail. However, many other people with these conditions are unaware of their risks or treatment options.

The Leukemia Lymphoma Society has set up a registry to provide information and antibody tests to people with blood cancer. Several studies are looking at the response to coronavirus vaccines in people with cancer, autoimmune diseases like lupus or rheumatoid arthritis, or in patients taking drugs that suppress the immune response.

What You Need To Know About The Johnson & Johnson Vaccine Break In The United States

    • On April 13, 2021, U.S. health officials called for an immediate halt to use of Johnson & Johnson’s single-dose Covid-19 vaccine after six recipients in the U.S. developed a rare blood clot disorder within one to three weeks of vaccination.
    • All 50 states, Washington, DC, and Puerto Rico have temporarily suspended use of the vaccine or suspended from recommended vendors. The U.S. military, government-run vaccination centers, and a variety of private companies, including CVS, Walgreens, Rite Aid, Walmart, and Publix, also paused the injections.
    • Fewer than one in a million Johnson & Johnson vaccinations are currently being studied. If there is indeed a risk of blood clots from the vaccine – which has yet to be determined – the risk is extremely small. The risk of contracting Covid-19 in the United States is much higher.
    • The hiatus could complicate the country’s vaccination efforts at a time when many states are facing spikes in new cases and are trying to address vaccine hesitation.
    • Johnson & Johnson has also decided to delay the launch of its vaccine in Europe amid concerns about rare blood clots, which is taking another blow to the vaccine surge in Europe. South Africa, devastated by a contagious variant of the virus found there, also stopped using the vaccine. Australia announced that it would not buy cans.

In one such study, British researchers tracked nearly 7,000 people with Crohn’s disease or ulcerative colitis from 90 hospitals across the country. They found that less than half of the patients who took Remicade had an immune response after contracting coronavirus infection.

In a follow-up, the scientists found that 34 percent of people who took the drug were protected after a single dose of the Pfizer vaccine and only 27 percent after a single dose of the AstraZeneca vaccine. (In the UK, the current practice is to delay second doses to increase vaccine availability.)

Likewise, another study published last month showed that fewer than 15 percent of patients with blood or immune cancer and fewer than 40 percent of patients with solid tumors produced antibodies after receiving a single dose of the Pfizer BioNTech vaccine.

And a study published last month in the journal JAMA reported that only 17 percent of the 436 transplant recipients who received a dose of the Pfizer BioNTech or Moderna vaccine had detectable antibodies three weeks later.

Despite the small likelihood, immunocompromised people should receive the vaccines because they may produce some immune cells that protect, even antibodies in a subset of patients.

“These patients should likely be prioritized for optimally balanced two doses,” said Dr. Tariq Ahmad, gastroenterologist with the Royal Devon and Exeter NHS Foundation Trust who was involved in the infliximab studies.

He suggested that doctors routinely measure antibody responses in immunocompromised people even after two doses of vaccine to identify those who may also need monoclonal antibodies to prevent infection or a third dose of the vaccines.

Wendy Halperin, 54, was diagnosed with a condition known as common variable immunodeficiency when she was 28 years old. She was hospitalized with Covid-19 in January and stayed there for 15 days. However, the coronavirus caused unusual symptoms.

“I had trouble walking,” she recalled. “I just lost control of my limbs like I couldn’t walk down the street.”

Since she was being treated for convalescence plasma for Covid-19, Ms. Halperin had to wait three months for the immunization and has made an appointment for April 26th. However, despite her condition, her body managed to produce some antibodies against the initial infection.

“The takeaway message is that everyone should try to get the vaccine,” said Dr. Amit Verma, oncologist at Montefiore Medical Center.

Gambling has settled in Dr. Wollowitz’s case not paid off. With no antibodies in his system to protect him, he still works from home – a privilege he is grateful for. He was an avid mountain biker and advanced skier, both of which were at risk of injury, but he is playing it safe with the coronavirus.

In anticipation of a return to his normal lifestyle, Dr. Wollowitz his bicycles. But he said he had foreseen he would live like this until enough other people are vaccinated and the number of infections in the city drops.

“I’m not exactly sure what that date is,” he said. “I’m really waiting to get out again.”

Categories
Politics

Fraudsters launder thousands and thousands by way of on-line funding platforms like Robinhood

Fraudsters launder millions through online investment platforms like Robinhood

Tech-savvy scammers stolen from Covid’s government pandid relief programs to help businesses launder the money conveniently: They’re opening accounts with at least four online investment platforms, police officers said.

The digital platforms, according to investigators, are easy to throw at the money by setting up accounts with stolen identities. According to the authorities, over $ 100 million in fraudulent funds have been transferred through investment accounts since Congress passed the CARES bill in March last year.

Thieves used Robinhood, TD Ameritrade, E-Trade and Fidelity to launder the money, law enforcement officials said.

The government swiftly launched the Paycheck Protection Program and the Economic Injury Disaster Loan (EIDL) program over the past year to help small businesses. Both programs were fraught with problems. In an inspector general’s report published last October, inadequate controls were blamed for potential billions in fraud.

CNBC policy

Read more about CNBC’s political coverage:

“The thieves love this stuff. This was the Bonanza Act on Financial Crime of 2021,” said Charles Intriago, a money laundering expert and former federal prosecutor.

Because of the size of the potential fraud, he said, law enforcement agencies are “facing a huge situation where the money is so massive, and the criminals see it as a great opportunity. They are taking the chance to tear it down.” . “

Roy Dotson, assistant to the special agent in charge of the secret service.

CNBC

A large number of money laundering investigations are ongoing, according to Roy Dotson, the secret service’s assistant special envoy who specializes in financial crimes.

“It’s definitely something that is visible to us. It uses all kinds of investment platforms,” ​​said Dotson.

Criminals take advantage of the ease of logging in to accounts and the relative anonymity compared to opening a bank account.

“It’s just one more layer that makes it difficult for law enforcement to understand where the funds are coming from,” he said.

Dotson would not discuss the names or the number of target companies. He would just say that it is “multiple investment platforms”.

He estimated that “more than $ 100 million went through these platforms”.

How the scam works

The scam usually works like this: the criminal steals a business owner’s identity and applies for a loan. Once they get the money, the money has to be deposited somewhere, making it difficult for investigators to track down. Therefore, fraudsters routinely use the stolen identity, which is usually an individual’s date of birth, social security number and other personal information, to open an investment account such as with Robinhood.

In other cases, police officers say, the criminals use something called a “synthetic identity”, a fictitious social security number tied to a real person, or “mules” involved in the system.

Robinhood, which was recently on the news due to a wave of retail investor interest sparked by so-called meme stocks like GameStop, has been targeted in several fraud cases investigated.

Det. Ricardo Peña of the Coral Springs, Florida Police Department.

CNBC

Ricardo Pena, a fraud investigator with the Coral Springs Police Department in Florida who is part of a federal anti-fraud task force, said he is investigating several cases where robinhood has been used by criminals to launder PPP funds and EIDL funds.

A scammer stole Marc Heiberg’s identity and was able to obtain $ 28,000 in EIDL funds to transfer to a Robinhood account.

CNBC

In one case, Pena said the scammer stole the identity of a local named Marc Heiberg and was able to obtain $ 28,000 in EIDL funds raised using fraudulent information for a nonexistent company with 60 employees. The scammer then opened a Robinhood account and attempted to transfer most of the money from a bank account using the victim’s identity.

Records show an “ACH reversal” three days after the account was opened, Pena said. That is, the transfer was reversed.

Heiberg, a corporate merchandising manager, said Robinhood told him that the fraudulent account was being investigated. The criminals also opened an account with Chase, he said.

“It just gets totally outrageous that they can just take anyone like me out there, take your social security number and open accounts with a bank, open accounts with the government and have the money deposited and then start laundering and laundering others Company, “said Heiberg.

He said he was concerned that other accounts might have been opened on his behalf.

“My name means everything to me. You know, I have, I have boys, I have a family. And I want their names to be intact too,” said Heiberg.

The Small Business Administration, which oversees the loan programs, told CNBC that “new, improved measures” have been in place to detect fraud since the first round of loans was launched last year.

In a statement, Amy Bonitatibus, Chase’s chief communications officer, said: “We are actively monitoring for signs of fraud and taking quick action to protect our customers. If so, we immediately identified suspicious activity on the account that helped prevent a Money was withdrawn or transferred. “

The security video shows a suspected fraudster attempting to withdraw money from an ATM in a Chase bank in Boca Raton, Florida.

Coral Springs Police Department.

Coral Springs’ detective, Pena, said he did not identify who set up the fraudulent accounts, but screenshots of security videos show a suspect trying to withdraw money from an ATM in the bank.

Suspicious scammer at a chase bank in Boca Raton, Florida.

Coral Springs Police Department.

He said Robinhood is often targeted for its attraction to younger people – and many of the criminals are in their twenties.

“You hear about it; everyone goes there. Even the criminals know about it,” Pena said. “A lot of the people who commit these scams are younger. They understand e-banking. Platforms like Robinhood are just easier to get those accounts to move money in and out of. And they know there isn’t that much control. “

Rick McDonell, executive director of the Association of Certified Anti-Money Laundering Specialists, said he was not surprised by this form of fraud.

“If I were a good criminal, I would avoid banks like the plague,” said McDonell, one of the world’s leading experts on money laundering.

Scammers are also drawn to the ease of use of Robinhood and other such platforms, said Etay Maor, senior director of security strategy at Cato Networks.

“It’s not like you have to go to a bank and show yourself,” Maor said. “The criminals do their homework and find the best way to deal with such high reward, low risk situations. By the time you find out the information, the money will be gone.”

The platforms react

Three of the investment platforms that responded to requests for comment told CNBC that they have strict anti-fraud protocols in place to verify account information and have worked with law enforcement agencies on the matter.

A Robinhood spokesperson said, “We are focused on preventing fraud before it occurs and our fraud and security teams have been working with law enforcement to mitigate and address this industry-wide problem. Like other brokers and financial institutions, Robinhood is reviewing new customer information across different data sources and may require government-issued IDs. “

A spokesman for TD Ameritrade said the company has “made efforts since the inception of the CARES Act to identify and mitigate on the front lines of this type of fraudulent activity, including working with law enforcement, peer firms and government agencies.”

It added that “there will always be bad actors trying to take advantage of vulnerable investors / people at every opportunity – that is precisely why we have processes and controls in place to identify and escalate this behavior.”

Fidelity said in a statement that it “has discovered accounts with suspicious deposits related to this industry-wide problem related to COVID-19 relief funds. We are in constant coordination with law enforcement agencies and their efforts in this regard.”

In addition, the company has a number of safeguards and multiple levels of security in place to detect fraudulent accounts and subsequent transactions. Some of our protections are inherently visible and some are not. To ensure the integrity of our security practices, it is inappropriate for us to comment on these specific safeguards any further. “

E-Trade did not respond to multiple emails and calls.

Other fraud

Some scammers using online investment platforms don’t even bother to steal an identity.

In a recent Seattle case, prosecutors accused technical director Mukund Mohan of obtaining $ 5.5 million in total PPP funding by filing fraudulent loan applications. Court records show that $ 231,471 was deposited into Mohan’s Robinhood account, the remainder at various banks.

Mohan, whose LinkedIn account lists him as a former Director of Engineering at Microsoft and Product Management Director at Amazon, has apologized for the fraud.

In a blog post last August after he was charged on the case, Mohan wrote, “I screwed it up. I can’t say no. I hurt people who trusted me, believed in me, and are now beside themselves Unfortunately, I am unable to speak about the details given the legal circumstances, but I really apologize. “

Mohan pleaded guilty to wired fraud and money laundering. The sentencing is scheduled for July. He declined CNBC’s request for comment.

Secret Service’s Dotson said the size of the entire fraud was staggering, a claim that has been confirmed by other federal agencies and departments.

The Department of Justice has seized or forfeited $ 626 million in criminal and civil investigations related to the PPP and EIDL programs, less than 1% of the nearly $ 84 billion fraud found in the programs said the House Select subcommittee on the coronavirus crisis.

“Because of the huge volume of the stimulus package, the amount of money and the opportunities, individuals have only used the different platforms,” ​​said Dotson.

Categories
Politics

Biden’s closest advisors have ties to huge enterprise with some making thousands and thousands

Biden’s closest advisors have ties to big business with some making millions

United States President Joe Biden speaks on vaccination status during a coronavirus disease (COVID-19) response in the East Room of the White House in Washington on March 18, 2021.

Carlos Barria | Reuters

President Joe Biden’s closest advisors are tied to big business and Wall Street. Some make millions of dollars in their careers before joining the White House.

Senior Biden personnel listed in the disclosures include Chief of Staff Ron Klain, Deputy Chief of Staff Jen O’Malley Dillon, Senior Advisor Mike Donilon, White House Coronavirus Response Coordinator Jeffrey Zients, and Director of the National Economic Council, Brian Deese.

These figures show that many of the President’s closest associates are closely connected to the business community and have made more money in their previous corporate careers than previously known.

This information was made available to CNBC by the White House early Saturday morning after the documents were requested the day before. None of these positions have been confirmed by the Senate. Many of these advisors are already linked to Biden’s campaign or the administration of former President Barack Obama.

A White House spokesman did not return a follow-up request for comment.

Deese was previously Global Head of Sustainable Investing at BlackRock before becoming head of the National Economic Council. During his tenure with the investment firm, Deese’s disclosure reveals that he has made over $ 2.3 million in salaries and bonuses. Its disclosure also suggests that Deese could have made an additional $ 2.4 million through BlackRock’s restricted share plan.

Klain, who was an executive at the venture capital firm Revolution prior to joining the White House, had a salary of $ 1.8 million. He started with the company in 2005.

O’Malley Dillon, who led Biden’s campaign before joining the White House, co-founded the consulting firm Precision Strategies. The company’s founders are credited with supporting Obama in the re-election in 2012.

O’Malley Dillon’s new financial disclosure provides a glimpse into the business advice she provided to the company before joining the White House. The file lists Gates Ventures as a client of O’Malley Dillon when she was with Precision Strategies.

According to PitchBook, Gates Ventures is a venture capital company founded by billionaire Bill Gates. The current White House Deputy Chief of Staff also advised the Chan Zuckerberg Initiative, the philanthropic arm of Facebook founder Mark Zuckerberg and his wife Priscilla Chan.

Other companies that saw their leadership were General Electric and Lyft. O’Malley Dillon’s deferred compensation and severance payment from Precision is reported to be in excess of $ 420,000.

Prior to joining the White House, Donilon was an executive member of MCD Strategies, a media consultancy. His filing shows that he has generated over $ 4 million in revenue as the head of his consulting firm. Donilon lists the Biden Campaign and the Democratic National Convention Committee as two of his clients.

Zients was the CEO of Wall Street investment firm Cranemere before becoming senior advisor to the White House in Biden on the coronavirus pandemic. His financial disclosure shows that he had a combined salary and bonus of $ 1.6 million. As a board member of Facebook, the new report reveals that he made over $ 330,000.

Categories
Politics

Home passes immigration payments establishing path to citizenship for hundreds of thousands

House passes immigration bills establishing path to citizenship for millions

House Speaker Nancy Pelosi (D-CA) speaks during a press conference on immigration at the U.S. Capitol on March 18, 2021 in Washington, DC.

Win McNamee | Getty Images

Legislators in the House of Representatives on Thursday passed two bills paving the way for the citizenship or legal status of millions of undocumented immigrants, including those illegally brought into the country as children and agricultural workers.

The law was passed largely partisan, with Democrats and Republicans.

The bills are tighter than the comprehensive immigration package launched in February with the assistance of President Joe Biden. Even so, they face a difficult path to the Senate, where 10 Republicans would have to vote with each Democrat to approve them.

A non-partisan immigration deal – a key priority for the Biden government – has been hampered by recent events. Republicans have noted an increase in unaccompanied minors arrested on the US-Mexico border to press for stricter immigration enforcement.

About 4,500 children are in the care of Customs and Border Protection, most of whom are in a facility in Donna, Texas, an administrative officer said Thursday. Under Biden, more unaccompanied children are allowed to enter the United States than under Trump, whose administration was quick to evict minors seeking entry into the country.

In a television interview on ABC Tuesday, Biden said, “I can be very clear, don’t come,” adding that “we’re in the process of settling in, don’t leave your town or town.” “

Continue reading: Apple CEO Tim Cook praises the Dreamer bill and calls on Congress to pass it

The government has asked the Federal Agency for Disaster Management to protect the minors and move them to more humane facilities while refusing to label the situation a “crisis” or an “emergency”. During a call to reporters on Wednesday, an unnamed administration official said the issue was older than the Biden administration and that legislation was needed to address it.

“This is quite a government effort. We are currently managing the situation, but it will take time for the damage caused to be repaired,” the official said. “We also need to work with Congress to pass an immigration law that will give us more sensible laws to implement and enforce.”

The two bills passed on Thursday are the American Dream and Promise Act and the Farm Workforce Modernization Act.

The first would apply largely to those immigrants known as dreamers who are protected under former President Barack Obama’s “Deferred Action for Child Arrivals 2012” program. About 2.5 million people who came to the United States as children are entitled to a path to citizenship under the law, according to the authors.

The bill was passed between 228 and 197, and nine Republicans joined the Democrats in favor of the legislation.

The second bill would provide farm workers illegally in the country with a route to legal status estimated at at least half of the 2.4 million workers in the sector. Some farm workers could get a green card if they pay a fine and stay in the industry for another four to eight years, depending on how long they have already worked on the farm.

The bills aren’t as extensive as Biden’s immigration plan, the US Citizenship Act of 2021, which would have opened up avenues to citizenship for most of the 11 million undocumented immigrants in the United States. Democratic and Republican leaders have said in recent days that such a sweeping proposal has virtually no chance of garnering bipartisan support.

“I see no way to do that,” Senator Dick Durbin, D-Ill., The Majority Whip, told CNN. “I want it. I think we’ll be much more likely to deal with discrete elements.”

Senator Lindsey Graham, RS.C., a Senate immigration leader, said Monday, “It’s going to be really difficult to put together a bipartisan bill on anything that has a legalization component until you stop the flow.”

The White House officially endorsed both bills early Thursday in statements calling on lawmakers to move forward with the citizenship bill.

Subscribe to CNBC Pro for the TV livestream, deep insights and analysis of how to invest during the next president’s term.